<DOC>
	<DOCNO>NCT01265589</DOCNO>
	<brief_summary>To research effect vitamin A newborn respiratory distress syndrome intratracheal administration surfactant .</brief_summary>
	<brief_title>Intratracheal Vitamin A Administration With Surfactant Newborn Respiratory Distress Syndrome</brief_title>
	<detailed_description>Chronic lung disease ( CLD ) prematurity major cause long-term disability extremely LBW ( ELBW ) premature infant , cost consumptive disease Neonatal Intensive Care Unit graduate . Vitamin A plays important role development premature lung . Nevertheless , premature infant prone vitamin A deficiency . Oral supplementation vitamin A alter incidence CLD ELBW infant . Intramuscular administration vitamin A reduce incidence CLD . The treatment consider painful way routinely practice . Vitamin A systemically bioavailable intratracheal administration surfactant animal model newborn respiratory distress .</detailed_description>
	<mesh_term>Respiratory Distress Syndrome , Newborn</mesh_term>
	<mesh_term>Respiratory Distress Syndrome , Adult</mesh_term>
	<mesh_term>Hyaline Membrane Disease</mesh_term>
	<mesh_term>Vitamins</mesh_term>
	<mesh_term>Vitamin A</mesh_term>
	<mesh_term>Pulmonary Surfactants</mesh_term>
	<mesh_term>Retinol palmitate</mesh_term>
	<criteria>1.Newborn infant birth weight &gt; 500 gm . 2.Gestational age &gt; 24 complete week . 3.Intention manage infant noninvasive respiratory support ( i.e . endotracheal tube ) , either : 1 ) infant within first 7 day life never intubate receive less 24 hour total cumulative intubate respiratory support ; 2 ) infant within first 28 day life , manage intubated respiratory support 24 hour candidate extubation follow noninvasive respiratory support . 4.No known lethal congenital anomaly genetic syndrome . 5.Signed parental inform consent 1.Considered nonviable clinician ( decision administer effective therapy ) 2.Lifethreatening congenital abnormality include congenital heart disease ( exclude patent ductus arteriosis ) 3.Infants know require surgical treatment 4.Abnormalities upper low airway 5.Neuromuscular disorder 6.Infants &gt; 28 day old continue require mechanical ventilation endotracheal tube</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>28 Days</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>RDS</keyword>
	<keyword>Infant , newborn</keyword>
	<keyword>Vitamin A</keyword>
	<keyword>Surfactant</keyword>
</DOC>